1. Home
  2. MYNA vs MYNZ Comparison

MYNA vs MYNZ Comparison

Compare MYNA & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNA
  • MYNZ
  • Stock Information
  • Founded
  • MYNA 2009
  • MYNZ 2021
  • Country
  • MYNA Germany
  • MYNZ Germany
  • Employees
  • MYNA N/A
  • MYNZ N/A
  • Industry
  • MYNA
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYNA
  • MYNZ Health Care
  • Exchange
  • MYNA Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • MYNA 11.2M
  • MYNZ 11.9M
  • IPO Year
  • MYNA 2021
  • MYNZ 2021
  • Fundamental
  • Price
  • MYNA $0.35
  • MYNZ $7.26
  • Analyst Decision
  • MYNA
  • MYNZ Hold
  • Analyst Count
  • MYNA 0
  • MYNZ 2
  • Target Price
  • MYNA N/A
  • MYNZ N/A
  • AVG Volume (30 Days)
  • MYNA 407.1K
  • MYNZ 167.6K
  • Earning Date
  • MYNA 02-18-2025
  • MYNZ 10-21-2024
  • Dividend Yield
  • MYNA N/A
  • MYNZ N/A
  • EPS Growth
  • MYNA N/A
  • MYNZ N/A
  • EPS
  • MYNA N/A
  • MYNZ N/A
  • Revenue
  • MYNA $5,957,776.00
  • MYNZ $917,203.00
  • Revenue This Year
  • MYNA $203.73
  • MYNZ $21.95
  • Revenue Next Year
  • MYNA $203.84
  • MYNZ $30.77
  • P/E Ratio
  • MYNA N/A
  • MYNZ N/A
  • Revenue Growth
  • MYNA 21.89
  • MYNZ 16.23
  • 52 Week Low
  • MYNA $0.33
  • MYNZ $0.18
  • 52 Week High
  • MYNA $5.89
  • MYNZ $7.95
  • Technical
  • Relative Strength Index (RSI)
  • MYNA 35.61
  • MYNZ 73.68
  • Support Level
  • MYNA $0.46
  • MYNZ $5.50
  • Resistance Level
  • MYNA $0.58
  • MYNZ $5.74
  • Average True Range (ATR)
  • MYNA 0.07
  • MYNZ 0.87
  • MACD
  • MYNA -0.01
  • MYNZ 0.26
  • Stochastic Oscillator
  • MYNA 3.98
  • MYNZ 87.38

About MYNA Mynaric AG American Depository Shares

Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: